Navigation Links
Pomegranate juice could kill cancer cells

Drinking an eight ounce glass of pomegranate juice daily could slow the progress of prostate cancer, minimise cell damage and could also kill cancer cells// , finds a new study.

Researchers led by Allan Pantuck at the University of California, Los Angeles, studied 50 men who had undergone surgery or radiation treatment for prostate cancer - but had shown signs that the disease was rapidly returning, reported the online edition of BBC News.

The presence of prostate cancer cells is monitored by measuring levels of a chemical they produce called prostate-specific antigen (PSA). The researchers measured how long it took for PSA levels to double in individual patients - a short doubling time indicates that the cancer is progressing quickly.

The average doubling time is about 15 months, but in patients who drank pomegranate juice, this increased to an average of 54 months.

Some patients continued to show suppressed PSA levels after more than three years, even though they were receiving no treatment apart from drinking pomegranate juice, said Pantuck.

The researchers added that the effect may be so large that it may help older men outlive the disease.

"There are many substances in pomegranate juice that may be prompting this response," said Pantuck.

"We are hoping we may be able to prevent or delay the need for other therapies usually used in this population such as hormone treatment or chemotherapy, both of which bring with them harmful side effects," added Pantuck.

Pomegranates have been linked to many health benefits. It contains a cocktail of chemicals including isoflavones, which are believed to play a role in cancer cell death.

Previous research, conducted through tests on mice, has indicated that pomegranate juice could have a beneficial effect on prostate cancer.
'"/>




Page: 1

Related medicine news :

1. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
2. Pomegranate juice to check fetal brain injury
3. Pomegranate juice delays prostate cancer
4. Pomegranate Juice Is Helpful In Arresting Osteoarthritis
5. Pomegranates Found To Slow Prostate Cancer Progression
6. Pomegranate Juice Consumption May Improve Myocardial Ischemia
7. Pomegranates In Snack-Sized Bars
8. Pomegranate Juice Remedy for Prostate Cancer
9. Pomegranate juice may cut atherosclerosis risk in diabetics
10. Science Builds Behind Pomegranate Extracts for Health
11. Drink grape juice for health
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2Health News:Industry Coalition Reissues Advisory Against Use of Dietary Supplements as Swine Flu Remedy, Cure 2Health News:Industry Coalition Reissues Advisory Against Use of Dietary Supplements as Swine Flu Remedy, Cure 3
Other Medicine News:Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 2Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 3Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 4Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 5Health News:91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs 6Health News:Study Challenges New Benchmark for High-Volume Heart Transplant Hospitals 2Health News:Samarion(SM) Announces Formation of Outcome Based Study Team for Industry's Only Enterprise Quality Improvement System 2Health News:Samarion(SM) Announces Formation of Outcome Based Study Team for Industry's Only Enterprise Quality Improvement System 3Health News:Onmark Launches Integrated Quality(TM) Program to Help Physicians Succeed With National Quality Initiatives 2Health News:Onmark Launches Integrated Quality(TM) Program to Help Physicians Succeed With National Quality Initiatives 3Health News:Onmark Launches Integrated Quality(TM) Program to Help Physicians Succeed With National Quality Initiatives 4Health News:Sonian Introduces the Most Affordable, Reliable and Scaleable Email Archiving Solution for All Messaging Systems 2Health News:MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2
Breaking Medicine Technology:Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 2Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 3Ambit Biosciences Corporation Presents Phase I Clinical Results of AC220 in Patients With Acute Myeloid Leukemia at ASH Conference 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Rampant helper syndrome 9100 1Rampant helper syndrome 9100 2Virus resistant grapevines 9098 1Virus resistant grapevines 9098 2Ferns took to the trees and thrived 9095 1Ferns took to the trees and thrived 9095 2